Related Experiment Video
Updated: Sep 21, 2025

09:16
Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
7.7K
Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
Cecilia Chavarría1, Rodrigo Ivagnes1, José M Souza1
1Departamento de Bioquímica, Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la República, Av. Gral. Flores 2125, 11400 Montevideo, Uruguay.
Biomolecules
|May 28, 2022
Summary
Extracellular alpha-synuclein (α-syn) aggregates activate glial cells, contributing to neuronal death in synucleinopathies. Understanding α-syn uptake mechanisms and receptors in glial cells is key for developing Parkinson
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alpha-synuclein (α-syn) is an intrinsically disordered protein implicated in neurodegenerative diseases.
- Extracellular α-syn aggregates are found in synucleinopathies and affect neuronal and glial cells.
- Glial activation, including microglial and astrocyte responses, contributes to neuronal damage.
Purpose of the Study:
- To review the mechanisms of extracellular alpha-synuclein uptake by glial cells.
- To examine the role of glial cell activation in synucleinopathies.
- To identify potential therapeutic targets for Parkinson's disease and related disorders.
Main Methods:
- Literature review focusing on extracellular α-syn aggregation and glial cell interactions.
- Analysis of receptor-mediated uptake pathways for α-syn in different glial cell types.
- Synthesis of data on the downstream effects of glial activation by α-syn.
Main Results:
- Extracellular α-syn species, particularly higher-ordered aggregates, trigger glial activation.
- Glial activation involves mitochondrial dysfunction, oxidative stress, and inflammatory responses.
- Specific receptors mediate the uptake of α-syn by glial cells, influencing disease progression.
Conclusions:
- Extracellular α-syn uptake and subsequent glial activation are critical pathological events in synucleinopathies.
- Targeting α-syn uptake mechanisms and receptors in glial cells offers a promising therapeutic strategy.
- Further research into these pathways could lead to novel treatments for Parkinson's disease.

